Successful treatment with omalizumab in challenge confirmed exercise-induced anaphylaxis

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	The Journal of Allergy and Clinical Immunology: In Practice
Vol/bind	5
Udgave nummer	1
Sider (fra-til)	204-206
ISSN	2213-2198
DOI	https://doi.org/10.1016/j.jaip.2016.09.035
Status	Udgivet - 1. jan. 2017

Dokumenter og links

@article{746d88f77f344ccd818a6b5a296708ba,

title = "Successful treatment with omalizumab in challenge confirmed exercise-induced anaphylaxis",

author = "{Junker Christensen}, Morten and Carsten Bindslev-Jensen",

year = "2017",

month = jan,

day = "1",

doi = "10.1016/j.jaip.2016.09.035",

language = "English",

volume = "5",

pages = "204--206",

journal = "The Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "American Academy of Allergy, Asthma and Immunology",

number = "1",

}

TY - JOUR

T1 - Successful treatment with omalizumab in challenge confirmed exercise-induced anaphylaxis

AU - Junker Christensen, Morten

AU - Bindslev-Jensen, Carsten

PY - 2017/1/1

Y1 - 2017/1/1

U2 - 10.1016/j.jaip.2016.09.035

DO - 10.1016/j.jaip.2016.09.035

M3 - Journal article

C2 - 27839749

SN - 2213-2198

VL - 5

SP - 204

EP - 206

JO - The Journal of Allergy and Clinical Immunology: In Practice

JF - The Journal of Allergy and Clinical Immunology: In Practice

IS - 1

ER -